...
首页> 外文期刊>Cancer genetics and cytogenetics >Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.
【24h】

Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.

机译:BRCA1 5382insC突变对巴西遗传性乳腺癌患者的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The 5382insC mutation in BRCA1 is a frequently reported mutation, being very prevalent in Central and Eastern Europe. This mutation was recurrently reported in Brazil and one case was reported Portugal, but not in Spain and other South-American countries,. We analyzed the haplotypic profile of seven Brazilian carriers of 5382insC to characterize a possible founder effect. The analyses indicated that mutation carriers shared an identical haplotype. The absence of this mutation in Spain, other South American countries, and sub-Saharan populations, as well as the patients' own ancestry, point to a significant Central or Eastern European contribution to the present genetic background of Brazilian population, different from the population structuring of remaining South American countries.
机译:BRCA1中的5382insC突变是一个经常报道的突变,在中欧和东欧非常普遍。该突变在巴西屡见不鲜,在葡萄牙报告一例,但在西班牙和其他南美国家未见报道。我们分析了5382insC的七个巴西载体的单倍型,以描述可能的创始人效应。分析表明,突变携带者具有相同的单倍型。在西班牙,其他南美国家和撒哈拉以南的人群中以及在患者的血统中没有这种突变,这表明中欧或东欧对巴西人群当前的遗传背景做出了重要贡献,与该人群不同其余南美国家的结构调整。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号